TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis

Éva Sághy(University of Pecs), Erika Pintér(Centre for Drug Research and Development), Sámuel Komoly(University of Pecs), Éva Sipos(University Hospital Augsburg), Krisztina Pohóczky(University of Pecs), Ágnes Kemény(Magyar Agrár- és Élettudományi Egyetem), Kata Bölcskei(University of Pecs), Péter Ács(University of Pecs), György Sétáló(University of Pecs), Sándor Zoltán(Gedeon Richter (Hungary)), Éva Szőke(University of Pecs)
Glia
August 29, 2016
10.1002/glia.23051
Cited by 58

Related Papers

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|587
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
|The Lancet|2008|276
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
|Neurobiology of Disease|2011|178
Herbal remedies of Solidago—correlation of phytochemical characteristics and antioxidative properties
|Journal of Pharmaceutical and Biomedical Analysis|2003|152
In vitro antioxidant properties of Helichrysum arenarium (L.) Moench
|Journal of Ethnopharmacology|2000|116